384 related articles for article (PubMed ID: 17461696)
1. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
Noviasky JA
Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
[TBL] [Abstract][Full Text] [Related]
2. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
Munger MA; Ng TM; Van Tassell BW
Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
[TBL] [Abstract][Full Text] [Related]
3. Nesiritide: harmful or harmless?
Dorsch MP; Rodgers JE
Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
[TBL] [Abstract][Full Text] [Related]
4. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
5. Nesiritide: trials and tribulations.
Arora RR
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
DeWald TA; Hernandez AF
Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
[TBL] [Abstract][Full Text] [Related]
7. [Nesiritide in heart failure: commercial success or therapeutic advance?].
Stampfli T; Perrier A
Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
Emerman CL
Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
[TBL] [Abstract][Full Text] [Related]
9. Short and long-term mortality with nesiritide.
Arora RR; Venkatesh PK; Molnar J
Am Heart J; 2006 Dec; 152(6):1084-90. PubMed ID: 17161057
[TBL] [Abstract][Full Text] [Related]
10. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
Dandamudi S; Chen HH
Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
[TBL] [Abstract][Full Text] [Related]
12. Intravenous nesiritide in acute heart failure.
Knox MA; Dancy T; Mook W; Pschirer JJ
Am J Ther; 2005; 12(3):233-7. PubMed ID: 15891267
[TBL] [Abstract][Full Text] [Related]
13. Effect of nesiritide in patients with acute decompensated heart failure.
O'Connor CM; Starling RC; Hernandez AF; Armstrong PW; Dickstein K; Hasselblad V; Heizer GM; Komajda M; Massie BM; McMurray JJ; Nieminen MS; Reist CJ; Rouleau JL; Swedberg K; Adams KF; Anker SD; Atar D; Battler A; Botero R; Bohidar NR; Butler J; Clausell N; Corbalán R; Costanzo MR; Dahlstrom U; Deckelbaum LI; Diaz R; Dunlap ME; Ezekowitz JA; Feldman D; Felker GM; Fonarow GC; Gennevois D; Gottlieb SS; Hill JA; Hollander JE; Howlett JG; Hudson MP; Kociol RD; Krum H; Laucevicius A; Levy WC; Méndez GF; Metra M; Mittal S; Oh BH; Pereira NL; Ponikowski P; Tang WH; Tanomsup S; Teerlink JR; Triposkiadis F; Troughton RW; Voors AA; Whellan DJ; Zannad F; Califf RM
N Engl J Med; 2011 Jul; 365(1):32-43. PubMed ID: 21732835
[TBL] [Abstract][Full Text] [Related]
14. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
15. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Emerman CL
Rev Cardiovasc Med; 2003; 4 Suppl 7():S13-20. PubMed ID: 14668696
[TBL] [Abstract][Full Text] [Related]
16. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
17. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.
Yancy CW
Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969
[TBL] [Abstract][Full Text] [Related]
18. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Aronson D; Burger AJ
Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
[TBL] [Abstract][Full Text] [Related]
19. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
Ezekowitz JA; Hernandez AF; Starling RC; Yancy CW; Massie B; Hill JA; Krum H; Diaz R; Ponikowski P; Metra M; Howlett JG; Gennevois D; O'Connor CM; Califf RM; Fonarow GC
Am Heart J; 2009 Feb; 157(2):219-28. PubMed ID: 19185628
[TBL] [Abstract][Full Text] [Related]
20. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
Sackner-Bernstein JD; Skopicki HA; Aaronson KD
Circulation; 2005 Mar; 111(12):1487-91. PubMed ID: 15781736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
